{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:24:55Z","timestamp":1761744295430,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2016]]},"DOI":"10.4158\/ep161367.co","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T15:12:19Z","timestamp":1465830739000},"page":"1132-1133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["The Significance of Thyroglobulin Antibodies in Papillary Thyroid Cancer"],"prefix":"10.1016","volume":"22","author":[{"given":"Kenneth A.","family":"Woeber","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.4158\/EP161367.CO_bb0010","doi-asserted-by":"crossref","first-page":"3615","DOI":"10.1210\/jc.2011-1740","article-title":"Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC)","volume":"96","author":"Spencer","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161367.CO_bb0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/thy.1994.4.199","article-title":"Significance of antithyroglobulin autoantibodies in differentiated thyroid carcinoma","volume":"4","author":"Kumar","year":"1994","journal-title":"Thyroid"},{"key":"10.4158\/EP161367.CO_bb0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1210\/jc.2007-1199","article-title":"Characterization of thyroglobulin epitopes in patients with autoimmune and non-autoimmune thyroid diseases using recombinant human monoclonal thyroglobulin autoantibodies","volume":"93","author":"Latrofa","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP161367.CO_bb0025","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/thy.2009.0384","article-title":"Thyroglobulin antibody is associated with increased cancer risk in thyroid nodules","volume":"20","author":"Kim","year":"2010","journal-title":"Thyroid"},{"key":"10.4158\/EP161367.CO_bb0030","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s002680020165","article-title":"Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited","volume":"25","author":"Kebebew","year":"2001","journal-title":"World J Surg"},{"key":"10.4158\/EP161367.CO_bb0035","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2265.2009.03537.x","article-title":"Coexistent chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma","volume":"71","author":"Kim","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.4158\/EP161367.CO_bb0040","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3346\/jkms.2012.27.8.883","article-title":"Coexistence of chronic lymphocytic thyroiditis with papillary thyroid carcinoma: clinical manifestation and prognostic outcome","volume":"27","author":"Jeong","year":"2012","journal-title":"J Korean Med Sci"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20416957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20416957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:01:50Z","timestamp":1761516110000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20416957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016]]}},"alternative-id":["S1530891X20416957"],"URL":"https:\/\/doi.org\/10.4158\/ep161367.co","relation":{},"ISSN":["1530-891X"],"issn-type":[{"type":"print","value":"1530-891X"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Significance of Thyroglobulin Antibodies in Papillary Thyroid Cancer","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP161367.CO","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}